Cellular GFP Toxicity and Immunogenicity: Potential Confounders in in Vivo Cell Tracking Experiments

Stem Cell Reviews and Reports

Volumn 12, Issue 5, 2016, Pages 553-559

  Ansari, Amir Mehdi ^a   Ahmed, A Karim ^a   Matsangos, Aerielle E ^a   Lay, Frank ^a   Born, Louis J ^a   Marti, Guy ^a   Harmon, John W ^a   Sun, Zhaoli ^b  

^a Department of Surgery and Hendrix Burn/Wound Laboratory ^*  (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell death; Cytotoxicity; Green fluorescent protein (GFP); Immunogenicity; In vivo cell tracking; Reporter gene

Indexed keywords

GREEN FLUORESCENT PROTEIN; REACTIVE OXYGEN METABOLITE; PHOTOPROTEIN;

CELL DAMAGE; CELL TRACKING; CYTOTOXICITY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ANIMAL; GENETICS; IMMUNOLOGY;

ANIMALS; CELL TRACKING; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS;

EID: 84978628285     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-016-9670-8     Document Type: Review

References (59)

1. Shimomura, O., Johnson, F. H., & Saiga, Y. (1962). Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea. Journal of Cellular and Comparative Physiology, 59, 223–239.
2. Morise, H., Shimomura, O., Johnson, F. H., & Winant, J. (1974). Intermolecular energy transfer in the bioluminescent system of Aequorea. Biochemistry, 13(12), 2656–2662.
3. Shimomura, O. (1979). Structure of the chromophore of Aequorea green fluorescent protein. FEBS Letters, 104(2), 220–222.
4. Prasher, D. C., Eckenrode, V. K., Ward, W. W., Prendergast, F. G., & Cormier, M. J. (1992). Primary structure of the Aequorea victoria green-fluorescent protein. Gene, 111(2), 229–233.
5. Chalfie, M., Tu, Y., Euskirchen, G., Ward, W. W., & Prasher, D. C. (1994). Green fluorescent protein as a marker for gene expression. Science, 263(5148), 802–805.
6. Skelton, D., Satake, N., & Kohn, D. B. (2001). The enhanced green fluorescent protein (eGFP) is minimally immunogenic in C57BL/6 mice. Gene Therapy, 8(23), 1813–1814.
7. Maeda, H., Shigoka, M., Wang, Y., Fu, Y., Wesson, R. N., Lin, Q., et al. (2014). Disappearance of GFP-positive hepatocytes transplanted into the liver of syngeneic wild-type rats pretreated with retrorsine. PloS One, 9(5), e95880.
8. Beagles, K. E., Peterson, L., Zhang, X., Morris, J., & Kiem, H. P. (2005). Cyclosporine inhibits the development of green fluorescent protein (GFP)-specific immune responses after transplantation of GFP-expressing hematopoietic repopulating cells in dogs. Human Gene Therapy, 16(6), 725–733.
9. Yang, Z., Wang, Y., Li, Y., Liu, Q., Zeng, Q., & Xu, X. (2014). Options for tracking GFP-Labeled transplanted myoblasts using in vivo fluorescence imaging: implications for tracking stem cell fate. BMC Biotechnology, 14, 55. doi:10.1186/1472-6750-14-55.
10. Gambotto, A., Dworacki, G., Cicinnati, V., Kenniston, T., Steitz, J., Tuting, T., et al. (2000). Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope. Gene Therapy, 7(23), 2036–2040.
11. Stripecke, R., Carmen Villacres, M., Skelton, D., Satake, N., Halene, S., & Kohn, D. (1999). Immune response to green fluorescent protein: implications for gene therapy. Gene Therapy, 6(7), 1305–1312.
12. Sattarzadeh, A., Saberianfar, R., Zipfel, W. R., Menassa, R., & Hanson, M. R. (2015). Green to red photoconversion of GFP for protein tracking in vivo. Scientific Reports, 5, 11771.
13. Liu, H. S., Jan, M. S., Chou, C. K., Chen, P. H., & Ke, N. J. (1999). Is green fluorescent protein toxic to the living cells? Biochemical and Biophysical Research Communications, 260(3), 712–717.
14. Matz, M. V., Fradkov, A. F., Labas, Y. A., Savitsky, A. P., Zaraisky, A. G., Markelov, M. L., et al. (1999). Fluorescent proteins from nonbioluminescent Anthozoa species. Nature Biotechnology, 17(10), 969–973.
15. Shaner, N. C., Campbell, R. E., Steinbach, P. A., Giepmans, B. N., Palmer, A. E., & Tsien, R. Y. (2004). Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nature Biotechnology, 22(12), 1567–1572.
16. Shaner, N. C., Lin, M. Z., McKeown, M. R., Steinbach, P. A., Hazelwood, K. L., Davidson, M. W., et al. (2008). Improving the photostability of bright monomeric orange and red fluorescent proteins. Nature Methods, 5(6), 545–551.
17. Shcherbo, D., Murphy, C. S., Ermakova, G. V., Solovieva, E. A., Chepurnykh, T. V., Shcheglov, A. S., et al. (2009). Far-red fluorescent tags for protein imaging in living tissues. The Biochemical Journal, 418(3), 567–574.
18. Kremers, G., Gilbert, S., Cranfill, P., Davidson, M., & Piston, D. (2011). Fluorescent proteins at a glance. Journal of Cell Science, 124, 157–160.
19. Lippincott-Schwartz, J., Altan-Bonnet, N., & Patterson, G. H. (2003). Photobleaching and photoactivation: following protein dynamics in living cells. Nature Cell Biology, Suppl, S7–14.
20. Snapp, E. (2005). Design and use of fluorescent fusion proteins in cell biology. Current protocols in cell biology/editorial board, Juan S. Bonifacino.. [et al.]; CHAPTER:Unit-21.4.
21. Taghizadeh, R. R. S. J. (2008). CFP and YFP, but not GFP, provide stable fluorescent marking of rat hepatic adult stem cells. Journal of Biomedicine and Biotechnology, 2008, 1–9.
22. Sherley, J. L. (2002). Asymmetric cell kinetics genes: the key to expansion of adult stem cells in culture. ScientificWorldJournal, 2, 1906–1921.
23. Inoue, H., Ohsawa, I., Murakami, T., Kimura, A., Hakamata, Y., Sato, Y., et al. (2005). Development of new inbred transgenic strains of rats with LacZ or GFP. Biochemical and Biophysical Research Communications, 329(1), 288–295.
24. Pletnev, S., Gurskaya, N. G., Pletneva, N. V., Lukyanov, K. A., Chudakov, D. M., Martynov, V. I., et al. (2009). Structural basis for phototoxicity of the genetically encoded photosensitizer KillerRed. The Journal of Biological Chemistry, 284(46), 32028–32039.
25. Granelli-Piperno, A., Keane, M., & Steinman, R. (1988). Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell. Transplantation, 46, 53S–60S.
26. Rosenzweig, M., Connole, M., Glickman, R., Yue, S. P., Noren, B., DeMaria, M., et al. (2001). Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells. Blood, 97(7), 1951–1959.
27. Mak, T.W., Saunders, M. E. (2005). The immune response: Basic and clinical principles. Academic Press.
28. Follenzi, A., Sabatino, G., Lombardo, A., Boccaccio, C., & Naldini, L. (2002). Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Human Gene Therapy, 13(2), 243–260.
29. Follenzi, A., Battaglia, M., Lombardo, A., Annoni, A., Roncarolo, M. G., & Naldini, L. (2004). Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood, 103(10), 3700–3709.
30. Fukudo, M., Yano, I., Masuda, S., Fukatsu, S., Katsura, T., Ogura, Y., et al. (2005). Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients. Clinical Pharmacology and Therapeutics, 78(2), 168–181.
31. Niwa, T., Yamamoto, S., Saito, M., Shiraga, T., & Takagi, A. (2007). Effect of cyclosporine and tacrolimus on cytochrome p450 activities in human liver microsomes. Yakugaku Zasshi, 127(1), 209–216.
32. Oertel, M., Rosencrantz, R., Chen, Y. Q., Thota, P. N., Sandhu, J. S., Dabeva, M. D., et al. (2003). Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors. Hepatology, 37(5), 994–1005.
33. Muraca, M., Ferraresso, C., Vilei, M. T., Granato, A., Quarta, M., Cozzi, E., et al. (2007). Liver repopulation with bone marrow derived cells improves the metabolic disorder in the Gunn rat. Gut, 56(12), 1725–1735.
34. Avital, I., Feraresso, C., Aoki, T., Hui, T., Rozga, J., Demetriou, A., et al. (2002). Bone marrow-derived liver stem cell and mature hepatocyte engraftment in livers undergoing rejection. Surgery, 132(2), 384–390.
35. Pfeifer, A., & Verma, I. M. (2001). Gene therapy: promises and problems. Annual Review of Genomics and Human Genetics, 2, 177–211.
36. Kim, T. K., & Eberwine, J. H. (2010). Mammalian cell transfection: the present and the future. Analytical and Bioanalytical Chemistry, 397(8), 3173–3178.
37. Woo, M., Hakem, R., Soengas, M. S., Duncan, G. S., & Shahinian, A. (1998). Kägi D, et al. essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes & Development, 12(6), 806–819.
38. Fernandes-Alnemri, T., Litwack, G., & Alnemri, E. S. (1994). CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. The Journal of Biological Chemistry, 269(49), 30761–30764.
39. Jiang, X., Sung, Y. K., Tian, W., Qian, J., Semenza, G. L., & Nicolls, M. R. (2014). Graft microvascular disease in solid organ transplantation. Journal of Molecular Medicine (Berlin), 92(8), 797–810.
40. Choy, J. C. (2010). Granzymes and perforin in solid organ transplant rejection. Cell Death and Differentiation, 17(4), 567–576.
41. Greenbaum, L., Rothmann, C., Lavie, R., & Malik, Z. (2000). Green fluorescent protein photobleaching: a model for protein damage by endogenous and exogenous singlet oxygen. Biological Chemistry, 381(12), 1251–1258.
42. Goto, H., Yang, B., Petersen, D., Pepper, K. A., Alfaro, P. A., Kohn, D. B., et al. (2003). Transduction of green fluorescent protein increased oxidative stress and enhanced sensitivity to cytotoxic drugs in neuroblastoma cell lines. Molecular Cancer Therapeutics, 2(9), 911–917.
43. Lee, H. S., Crane, G. G., Merok, J. R., Tunstead, J. R., Hatch, N. L., Panchalingam, K., et al. (2003). Clonal expansion of adult rat hepatic stem cell lines by suppression of asymmetric cell kinetics (SACK). Biotechnology and Bioengineering, 83(7), 760–771.
44. Huang, W. Y., Aramburu, J., Douglas, P. S., & Izumo, S. (2000). Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nature Medicine, 6(5), 482–483.
45. Agbulut, O., Huet, A., Niederlander, N., Puceat, M., Menasche, P., & Coirault, C. (2007). Green fluorescent protein impairs actin-myosin interactions by binding to the actin-binding site of myosin. The Journal of Biological Chemistry, 282(14), 10465–10471.
46. Agbulut, O., Coirault, C., Niederlander, N., Huet, A., Vicart, P., Hagege, A., et al. (2006). GFP expression in muscle cells impairs actin-myosin interactions: implications for cell therapy. Nature Methods, 3(5), 331.
47. Krestel, H. E., Mihaljevic, A. L., Hoffman, D. A., & Schneider, A. (2004). Neuronal co-expression of EGFP and beta-galactosidase in mice causes neuropathology and premature death. Neurobiology of Disease, 17(2), 310–318.
48. Morys, M., Berger, D. (1993). Accurate measurements of biologically effective ultraviolet radiation. Proc. SPIE 2049, Atmospheric Radiation, 152. doi:10.1117/12.163506.
49. Setlow, R. B., Grist, E., Thompson, K., & Woodhead, A. D. (1993). Wavelengths effective in induction of malignant melanoma. Proceedings of the National Academy of Sciences of the United States of America, 90(14), 6666–6670.
50. Rozanowska, M., Jarvis-Evans, J., Korytowski, W., Boulton, M. E., Burke, J. M., & Sarna, T. (1995). Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species. The Journal of Biological Chemistry, 270(32), 18825–18830.
51. Magidson, V., & Khodjakov, A. (2013). Circumventing photodamage in live-cell microscopy. Methods in Cell Biology, 114, 545–560.
52. Wiedenmann, J., Oswald, F., & Nienhaus, G. U. (2009). Fluorescent proteins for live cell imaging: opportunities, limitations, and challenges. IUBMB Life, 61(11), 1029–1042.
53. Dou, C., Lay, F., Ansari, A. M., Rees, D. J., Ahmed, A. K., Kovbasnjuk, O., et al. (2014). Strengthening the skin with topical delivery of keratinocyte growth factor-1 using a novel DNA plasmid. Molecular Therapy, 22(4), 752–761.
54. Zhao, Y., Bower, A. J., Graf, B. W., Boppart, M. D., & Boppart, S. A. (2013). Imaging and tracking of bone marrow-derived immune and stem cells. Methods in Molecular Biology, 1052, 57–76.
55. Alvarez-Dolado, M., Pardal, R., Garcia-Verdugo, J. M., Fike, J. R., Lee, H. O., Pfeffer, K., et al. (2003). Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature, 425(6961), 968–973.
56. Vassilopoulos, G., Wang, P. R., & Russell, D. W. (2003). Transplanted bone marrow regenerates liver by cell fusion. Nature, 422(6934), 901–904.
57. Frame, F. M., Hager, S., Pellacani, D., Stower, M. J., Walker, H. F., Burns, J. E., et al. (2010). Development and limitations of lentivirus vectors as tools for tracking differentiation in prostate epithelial cells. Experimental Cell Research, 316(19), 3161–3171.
58. Hellweg, C. E., Baumstark-Khan, C., & Horneck, G. (2001). Enhanced green fluorescent protein as reporter protein for biomonitoring of cytotoxic effects in mammalian cells. Analytica Chimica Acta, 427(2), 191–199.
59. Jessen, B., Faller, S., Krempl, C. D., & Ehl, S. (2011). Major histocompatibility complex-dependent cytotoxic T lymphocyte repertoire and functional avidity contribute to strain-specific disease susceptibility after murine respiratory syncytial virus infection. Journal of Virology, 85(19), 10135–10143.